In: Elsner P., Maibach H., eds
Cagrilintide Safety and Risks As with any investigational peptide , cagrilintide should be used with clinical caution , particularly in populations with pre-existing endocrine or gastrointestinal disorders
Dual Action Mechanism :Tirzepatide's capability to target both GLP- 1 and GIP receptors sets it piecemeal from other curatives
But theres tension here, both scientifically and culturally
Drug families known to disrupt HPG axis signaling and/or decrease fertility by other mechanisms include 23 : Chemotherapy drugs (such as cisplatin, doxorubicin (Adriamycin, among others), 5-fluorouricil (5-FU), cyclophosphamide) 52 Psychiatric medications 23 Corticosteroids and other immune suppressants 23,69 Some blood pressure-lowering drugs including calcium channel blockers, angiotensin receptor blockers (ARBs), and angiotensin-converting enzyme inhibitors (ACEi)